Pembrolizumab after platinum-based chemotherapy for treatment of metastatic bladder cancer

被引：0
|
作者：
Richters, A. [1 ]
Van der Heijden, A. G. [2 ]
Mehra, N. [3 ]
Meijer, R. P. [4 ]
Kiemeney, L. A. [5 ]
Boormans, J. L. [6 ]
Aben, K. [1 ]
机构：
[1] Netherlands Comprehens Canc Org, Dept Res, Utrecht, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Urol, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen Med Ctr, Dept Med Oncol, Nijmegen, Netherlands
[4] Univ Med Ctr Utrecht, Dept Urol, Utrecht, Netherlands
[5] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands
[6] Erasmus MC, Dept Urol, Rotterdam, Netherlands
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0751
引用
收藏
页码：S1728 / S1728
页数：1
相关论文
共 50 条
  • [1] Paclitaxel and carboplatin chemotherapy after platinum-based chemotherapy and pembrolizumab for metastatic urothelial carcinoma
    Furubayashi, Nobuki
    Hori, Yoshifumi
    Morokuma, Futoshi
    Tomoda, Toshihisa
    Negishi, Takahito
    Inoue, Tomohiro
    Kumagai, Masatoshi
    Kuroiwa, Kentaro
    Tokuda, Noriaki
    Nakamura, Motonobu
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (05)
  • [2] PLATINUM-BASED CHEMOTHERAPY FOR BLADDER-CANCER
    WAXMAN, J
    WASAN, H
    [J]. SEMINARS IN ONCOLOGY, 1994, 21 (05) : 54 - 60
  • [3] The Renaissance of Platinum-Based Chemotherapy for Metastatic Breast Cancer
    Meriggi, F.
    Di Biasi, B.
    Zaniboni, A.
    [J]. JOURNAL OF CHEMOTHERAPY, 2008, 20 (05) : 551 - 560
  • [4] Organ-Specific Therapeutic Effect of Paclitaxel and Carboplatin Chemotherapy After Platinum-Based Chemotherapy and Pembrolizumab for Metastatic Urothelial Carcinoma
    Furubayashi, Nobuki
    Negishi, Takahito
    Miura, Akihiro
    Nakamura, Nobutaka
    Nakamura, Motonobu
    [J]. RESEARCH AND REPORTS IN UROLOGY, 2020, 12 : 455 - 461
  • [5] Platinum-based chemotherapy in metastatic breast cancer: current status
    Decatris, MP
    Sundar, S
    O'Byrne, KJ
    [J]. CANCER TREATMENT REVIEWS, 2004, 30 (01) : 53 - 81
  • [6] Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
    Martina Catalano
    Andrea Lapucci
    Stefania Nobili
    Irene De Gennaro Aquino
    Ismaela Anna Vascotto
    Lorenzo Antonuzzo
    Donata Villari
    Gabriella Nesi
    Enrico Mini
    Giandomenico Roviello
    [J]. Cancer Chemotherapy and Pharmacology, 2024, 93 : 1 - 9
  • [7] Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
    Catalano, Martina
    Lapucci, Andrea
    Nobili, Stefania
    De Gennaro Aquino, Irene
    Vascotto, Ismaela Anna
    Antonuzzo, Lorenzo
    Villari, Donata
    Nesi, Gabriella
    Mini, Enrico
    Roviello, Giandomenico
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (01) : 1 - 9
  • [8] Maintenance Therapy with Pembrolizumab after Platinum-Doublet Chemotherapy Leading to Hyperprogression in a Patient with Metastatic Bladder Cancer
    Gu, Yangchun
    He, Huiying
    Wang, Mopei
    [J]. ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2021, 8 (05) : 586 - 590
  • [9] Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer
    Shamseddine, Ali I.
    Farhat, Fadi S.
    [J]. CHEMOTHERAPY, 2011, 57 (06) : 468 - 487
  • [10] A phase II trial with copanlisib plus avelumab as maintenance therapy for metastatic bladder cancer after platinum-based chemotherapy.
    Farrukh, Hizra
    Zhu, Zheng
    Zhu, Shaoming
    Montgomery, Robert Bruce
    Meeks, Joshua J.
    VanderWeele, David James
    Wong, Yu-Ning
    Lew, Robert A.
    Pan, Chong-xian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345